The FT features DNA Electronics in article on biomedical technology commercialisation

In a full-page feature in the Financial Times, Professor Chris Toumazou, co-founder and CEO of DNA Electronics is profiled as the driving force behind the creation of the Institute of Biomedical Engineering, Imperial College London.  The IBE is a world-class postgraduate research institute, with a focus on new technology commercialisation.  DNA Electronics and the application of its technology in pharmacogenetic testing for predicting drug response are described alongside other spin-out companies from the IBE in Clive Cookson's article, which appeared in print on Wednesday 6th February 2008.  More details and a video interview with Prof Toumazou available online at FT.com.

DNA Electronics granted UK patent for ultra-low power circuits

The UK Intellectual Property Office has today advised that DNA Electronics will be granted a patent for its low-power chip-based sensor interfaces on 20 February 2008.  This is the second patent in ultra-low power electronic circuits to be secured by DNA Electronics, building upon existing protection secured in the United States and Europe.  The company has also been granted international patents in the core Genalysis™ detection platform, a novel combination of silicon chip sensors and biochemistry on a disposable chip, harnessing the economies of scale of silicon manufacturing for genetic testing.   DNA Electronics is continuing to invest in its growing intellectual property portfolio to secure protection and manoeuvrability in the major global markets.